Catalyst Wire Dossier Catalyst Wire Dossier

Vyxeos liposomal

daunorubicin hydrochloride; cytarabine (liposomal formulation) · Jazz Pharmaceuticals Ireland Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vyxeos liposomal, covering 2024-05-24 to 2026-08-04. Get the full timeline:

Most recent: EMA Authorised: Vyxeos liposomal (previously Vyxeos) (daunorubicin hydrochloride;cytarabine) — Jazz Pharmaceuticals Ireland Limited

See pricing